On Oct. 25, 2023, ASE released a policy statement for the use of artificial intelligence (AI) in cardiovascular medicine. ASE supports the integration of AI in cardiovascular ultrasound to enhance efficiency, improve patient outcomes, and promote equitable, cost-effective care, while urging careful consideration of its development and use. ASE emphasizes the need for standardized AI terminology, transparent FDA-authorized validation processes, and payment models that recognize the continued role of clinicians in AI-supported care. Additionally, ASE calls for balanced liability structures to encourage innovation without placing undue risk on healthcare providers.
Publishing date
October 24, 2025
Related Resources
Advocacy
ASE Joins Coalition Supporting Robust NIH Funding and Oversight of Federal Research Barriers
On June 16, ASE joined a broad coalition...
Advocacy
ASE Joins Coalition Requesting a Fix for the Efficiency Adjustment to be Added to Physician Payment Reform
On June 15, ASE joined twenty undersigned organizations...
Advocacy
ASE Joins Comments on the CMS/ONC Interoperability Standards and Prior Authorization for Drugs Proposed Rule
On June 15, ASE joined the Alliance of...